Regeneron Pharmaceuticals Inc. buy gerihouse
Summary
This prediction ended on 27.04.20 with a price of €508.40. The BUY prediction by gerihouse finished with a performance of 27.08%. gerihouse has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Regeneron Pharmaceuticals Inc. | -1.669% | -1.669% | 40.445% | 92.256% |
iShares Core DAX® | -5.585% | -6.284% | 8.869% | 8.070% |
iShares Nasdaq 100 | -7.241% | -13.117% | 18.200% | 28.955% |
iShares Nikkei 225® | -8.933% | -10.904% | 2.614% | -1.478% |
iShares S&P 500 | -6.148% | -7.562% | 17.896% | 31.811% |
Comments by gerihouse for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.